Development of Aqueous Parenteral Formulations for Carbamazepine through the Use of Modified Cyclodextrins
- 1 April 1991
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 80 (4), 380-383
- https://doi.org/10.1002/jps.2600800420
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys☆International Journal of Pharmaceutics, 1990
- The use of 2-hydroxypropyl-β-cyclodextrin as a vehicle for intravenous administration of dexamethasone in dogsInternational Journal of Pharmaceutics, 1990
- Improved Anticonvulsant Activity of Phenytoin by a Redox Brain Delivery System III: Brain Uptake and Pharmacological EffectsJournal of Pharmaceutical Sciences, 1989
- Carbamazepine UpdateThe Lancet, 1989
- Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrinsInternational Journal of Pharmaceutics, 1988
- Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugsInternational Journal of Pharmaceutics, 1986
- Hydrophilic Cyclodextrin Derivatives Enable Effective Oral Administration of Steroidal HormonesJournal of Pharmaceutical Sciences, 1986
- The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of miceNeuropharmacology, 1983